Amundi Cuts Stock Position in Docusign Inc. $DOCU

Amundi lessened its position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 53.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 646,111 shares of the company's stock after selling 733,464 shares during the quarter. Amundi owned 0.32% of Docusign worth $49,990,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Hemington Wealth Management grew its stake in Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after purchasing an additional 264 shares during the last quarter. Golden State Wealth Management LLC boosted its stake in shares of Docusign by 519.4% in the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after buying an additional 322 shares during the last quarter. Summit Securities Group LLC purchased a new stake in shares of Docusign in the first quarter worth about $34,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Docusign in the fourth quarter worth about $37,000. Finally, McIlrath & Eck LLC boosted its stake in shares of Docusign by 476.0% in the fourth quarter. McIlrath & Eck LLC now owns 432 shares of the company's stock worth $39,000 after buying an additional 357 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

Insiders Place Their Bets

In other Docusign news, CFO Blake Jeffrey Grayson sold 15,143 shares of the firm's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the completion of the sale, the chief financial officer owned 110,723 shares of the company's stock, valued at $8,282,080.40. This trade represents a 12.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Robert Chatwani sold 22,875 shares of the firm's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total value of $1,710,821.25. Following the sale, the insider directly owned 72,126 shares of the company's stock, valued at approximately $5,394,303.54. This trade represents a 24.08% decrease in their position. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock worth $5,983,631 in the last three months. 1.01% of the stock is owned by insiders.

Docusign Stock Up 1.8%

Shares of NASDAQ DOCU traded up $1.45 during midday trading on Thursday, hitting $80.27. The stock had a trading volume of 2,463,495 shares, compared to its average volume of 2,674,016. The company has a market capitalization of $16.14 billion, a PE ratio of 60.30, a P/E/G ratio of 4.18 and a beta of 1.02. The stock has a 50 day simple moving average of $75.69 and a 200-day simple moving average of $79.29. Docusign Inc. has a 1 year low of $55.14 and a 1 year high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm had revenue of $800.64 million during the quarter, compared to analysts' expectations of $780.35 million. During the same quarter last year, the firm earned $0.97 earnings per share. The business's revenue for the quarter was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, analysts expect that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its board has initiated a stock repurchase program on Thursday, June 5th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to buy up to 6.6% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on DOCU shares. Piper Sandler upped their target price on Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a research note on Friday, September 5th. Zacks Research upgraded Docusign from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. Morgan Stanley increased their price target on Docusign from $86.00 to $90.00 and gave the stock an "equal weight" rating in a research report on Monday. JPMorgan Chase & Co. increased their price target on Docusign from $77.00 to $80.00 and gave the stock a "neutral" rating in a research report on Friday, September 5th. Finally, Wells Fargo & Company increased their price target on Docusign from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $94.14.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.